|
Unmet need in adults and adolescents and young adults (AYAs) with B-cell acute lymphoblastic leukemia (B-ALL) in the US following a second relapse. |
| |
|
Consulting or Advisory Role - Bioheng; Jazz Pharmaceuticals; Sanofi; Takeda |
Research Funding - Actinium Pharmaceuticals (Inst); Amgen (Inst); Sanofi; Tigen Pharma |
Travel, Accommodations, Expenses - Takeda |
| |
|
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Arcellx; AstraZeneca; Jazz Pharmaceuticals; Prothena; Sanofi |
| |
|
|
Leadership - AstraZeneca Canada |
Stock and Other Ownership Interests - AstraZeneca |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
| |
|
Employment - AbbVie; AstraZeneca |
Stock and Other Ownership Interests - AstraZeneca |
Consulting or Advisory Role - AbbVie |
Research Funding - AbbVie; AstraZeneca |
Travel, Accommodations, Expenses - AbbVie; AstraZeneca Canada |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
Travel, Accommodations, Expenses - Flatiron Health |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Autolus Therapeutics; Kite/Gilead; Takeda |
Research Funding - Abbvie |
| |
|
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma; Autolus; Bristol-Myers Squibb; Genentech; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; TargetRX; Terns Pharmaceuticals |
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma Group; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Terns Pharmaceuticals; TGRX |
Travel, Accommodations, Expenses - Aptitude Health; Autolus; Daiichi Sankyo Nordics; HMP Education; MD Education; Nucleus Global; ONVIV; Pfizer |